Welcome to the Pharmaceutical Bioprocessing

ISI-ESCI Indexed

Pharmaceutical Bioprocessing as a field of study has gained great significance at with advancements in the field of biomedical research paving the way for innovative pharmaceutical products. Pharmaceutical Bioprocessing Journal thus discusses the latest happenings in the drug design, production and delivery in order to offer efficient solutions to mitigate the public health concerns.

This scholarly journal offers an Open Access platform to the scholars, amateurs, clinical practitioners and students that are keen in contributing their findings in this field. The journal includes wide areas of studies in this field by including topics like Process design, development, scale-up and automation; Production facilities, equipment and the use of disposables; Cell expression systems for biopharmaceutical production; Bioreactors, Upstream and downstream processing; Bio-containment, safety and cGMP processes; Production of recombinant proteins, mAbs, vaccines and cell therapies; Analysis: processing design, process analytics and release criteria; Bioformulation, validation, regulation and patient delivery; Regulatory issues and other areas of debate; Disposable Bioprocessing Systems.

Not limited to the categories mentioned above the journal offers thoroughly reviewed original research as research articles, review articles, case studies, commentaries, Short Communication, and Letters to the Editors in this field.

Indexing Information: Pharmaceutical Bioprocessing Journal is indexed in the quality indexing sites such as ISI-ESCI, Chemical Abstracts for increasing visibility and discoverability.


*2017 Journal Impact Factor was established by dividing the number of articles published in 2015 and 2016 with the number of times they are cited in 2017 based on Google Scholar Citation Index database. If 'X' is the total number of articles published in 2015 and 2016, and 'Y' is the number of times these articles were cited in indexed journals during 2017 then, journal impact factor = Y/X

Recently Published Articles

Research Article p. 93-105

CD146 expression, as a surrogate biomarker for human mesenchymal stromal cell multilineage differentiation, is preserved during cell expansion in an automated hollow-fiber membrane bioreactor

Author(s): Jones M, Nankervis B, Frank N, Vang B, DiLorenzo T, Hill D & Coeshott C

Background: Mesenchymal stromal cells (also known as mesenchymal stem cells, hMSCs) are currently being evaluated in a number of clinical trials including those for graft-versus-host disease..

Research Article p. 113-118

The therapeutic effect of combined therapy of hemopoietin and methylprednisolone in treatment of spinal cord ischemia-reperfusion injury of patient with cervical spondylotic myelopathy and its influence to the level of serum IL-1β, IL-1Ra and IL- 8

Author(s): Qin Hao, Juan Shen & Lin Zhao

Purpose: To study thetherapeutic effect of combined therapy of hemopoietin and methylprednisolone in treatment of spinal cord ischemia-reperfusion injury and explore the its influence to the..